Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
Still a chance to return to 1.5C climate goal, researchers say
6/11/2025
Championship roundup : Saints beat QPR, Small stunner inspires Preston
6/11/2025
Lancashire’s Reform-run council plans to close care homes and day centres
6/11/2025
Phil Foden’s double downs Borussia Dortmund as Manchester City sparkle
6/11/2025
Burn and Joelinton use their heads to give Newcastle win over Bilbao
5/11/2025
Director of Kim Kardashian show All’s Fair responds to scathing reviews : ‘Hopefully opinions will change’
5/11/2025